γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Titel:
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Auteur:
Cowan, Andrew J Pont, Margot J Sather, Blythe D Turtle, Cameron J Till, Brian G Libby 3rd, Edward N Coffey, David G Tuazon, Sherilyn A Wood, Brent Gooley, Ted Wu, Vicky Q Voutsinas, Jenna Song, Xiaoling Shadman, Mazyar Gauthier, Jordan Chapuis, Aude G Milano, Filippo Maloney, David G Riddell, Stanley R Green, Damian J